Viscosupplement drugs can be administered using single injection, three injections, and five injections. These injections are used for arthritis for all types of joint.
Viscosupplementation Market: Overview
- Viscosupplement drugs can be administered using single injection, three injections, and five injections. These injections are used for arthritis for all types of joint.
- In this procedure, a gel-like fluid called hyaluronic acid is injected into the joint
- The three injections segment dominated the global viscosupplementation market in 2018. Growth of the segment can be attributed to increase in demand for viscosupplement injections and rise in adoption of this therapy.
- Rise in prevalence of osteoarthritis among the geriatric population is a major factor boosting the growth of the global viscosupplementation market. The prevalence of osteoarthritis is high among the elderly population and increases with age. An article published by the Geriatric Orthopedic Surgery & Rehabilitation in 2015 stated that osteoarthritis (OA) is the most common age-related joint disease affecting over 80% people aged above 55.
- Surge in demand for minimally invasive surgery is another factor fueling the growth of the global viscosupplementation market. Viscosupplement injection is a minimally invasive therapy for osteoarthritis, which minimizes blood loss, reduces hospital stay, offers quicker rehabilitation, and smaller incision. Rise in inclination toward minimally invasive surgery drives demand for viscosupplementation.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10232
Rise in Awareness about New Drugs for Treatment
- Rise in awareness about new drugs for treatment propels the global market. Knee osteoarthritis is a leading cause of disability among the geriatric population. Therapeutic options for knee OA include non-pharmacologic, pharmacologic, and surgical interventions. Joint replacement surgery is generally reserved for patients who do not respond to other treatments. An article published in NCBI in 2015 indicated that treatments considered to be most effective include viscosupplement injections (74.1%), narcotics (67.8%), and steroid injection (67.6%).
Request for Analysis of COVID19 Impact on Viscosupplementation Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=10232
Market Segmentation: Viscosupplementation Market
- Based on product type, the global viscosupplementation market has been divided into single injection, three injections, and five injections
- In terms of application, the global viscosupplementation market has been classified into knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis
- Based on source, the global viscosupplementation market has been bifurcated into animal and non-animal
- In terms of distribution channel, the global viscosupplementation market has been categorized into retail pharmacies, hospital pharmacies, and online pharmacies
- Each of the segments has been analyzed in detail for market trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027 along with market size estimations.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=10232
Geographic Overview: Viscosupplementation Market
- In terms of region, the global viscosupplementation market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
- The current and future market sizes in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGRs for the period from 2019 to 2027
- The study also offers a list of recommendations, highlights, and useful insights of the market which will help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process
Pre book Viscosupplementation Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=10232<ype=S
Major Players
- The report concludes with the company profiles section that includes key information about the major players in the market
- Leading players analyzed in the report are
- Sanofi
- Anika Therapeutics, Inc.
- Seikagaku Corporation
- Zimmer Biomet
- Ferring B.V.
- LG Chem
- Chugai Pharmaceutical Co., Ltd,
- Bioventus, Inc.
- Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453